Viking Therapeutics, Inc. (VKTX)
33.69
-0.23
(-0.68%)
USD |
NASDAQ |
Jan 20, 11:11
Viking Therapeutics EPS Basic from Accounting Change (Quarterly)
EPS Basic from Accounting Change (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Basic from Accounting Change (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| Pfizer Inc. | -- |
| Amgen, Inc. | -- |
| Altimmune, Inc. | -- |
| Moderna, Inc. | -- |